Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 10—October 2006
Books and Media

Epstein-Barr Virus (Infectious Disease and Therapy)

Cite This Article

Alex Tselis; Hal B. Jenson, editors
Informa Healthcare, New York, New York, 2006
ISBN: 0824754255
Pages: 436; Price US $189.95

Epstein-Barr virus (EBV) was the first recognized human tumor virus, but it is not the causative agent for the tumor in which it was discovered, Burkitt lymphoma. Common to all Burkitt lymphomas, endemic or sporadic, are distinctive chromosomal translocations that reactivate expression of the c-myc protooncogene and comprise the primary oncogenic mechanism.

EBV is at least a contributory cofactor in endemic Burkitt lymphoma, but the virus is detected in <20% of sporadic cases in the United States. EBV does cause infectious mononucleosis, hairy leukoplakia, and B-lymphoproliferative neoplasms in immunocompromised persons. In addition, the early and utterly consistent presence of monoclonal EBV episomes in nasopharyngeal carcinoma worldwide suggests a crucial role for the virus in that neoplasm. While tantalizing, associations with other diseases, well reviewed in this volume, are inconsistent and suggest that the virus may have another role beyond the etiologic, namely, by affecting the phenotype of already existing tumor cells and possibly propelling tumor progression.

This book is assembled mostly from a clinical perspective, and useful chapters on several of the EBV diseases bring together information not easily found elsewhere. Well-informed chapters on the virology and epidemiology of EBV infection are also included. One of the editors (whose list of milestones displays the clinical emphasis of the book) has provided a nice historical summary.

As is usual with such compilations, the editors leave it to the contributors to speak for themselves, and the quality of the chapters is uneven. Some fall short in citation of primary sources or favor the author's view rather than one that weighs all the evidence. Withal it is a useful book, and having the less often discussed associations such as T-cell lymphomas and leiomyosarcomas assigned a place alongside authoritative chapters on the classic associations, nasopharyngeal carcinoma and Burkitt lymphoma, is convenient. The volume ends with a chapter on an EBV vaccine, which remains elusive after many years. In contrast, the penultimate chapter includes a brief summary of some successes with adoptive immunotherapy for posttransplant lymphoproliferative disease, which is generally refractory to conventional treatment. This volume is worth having for the cross-section of knowledge and developments in the EBV field it presents.


Joseph Pagano*
Author affiliation: *University of North Carolina, Chapel Hill, North Carolina, USA


Cite This Article

DOI: 10.3201/eid1210.060778

Related Links


Table of Contents – Volume 12, Number 10—October 2006

Page created: December 09, 2011
Page updated: December 09, 2011
Page reviewed: December 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.